Day One Biopharmaceuticals Overview
Day One Biopharmaceuticals Target Price
Analysts' 12-month price predictions for DAWN.
Get informed when a big investor buys or sells
+ FollowShare Price
$21.53
Average Target Price
$21.50
0.1% downside
0.1% downside1 analysts in the last 4 months
High: $21.5 | Low: $21.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-10 | H.C. WainwrightAndrew Maldonado | $21.5 | 0.1% downside |  |
| 2025-11-05 | Piper Sandler | $26 |  20.8% upside | |
| 2024-08-01 | Bank of America SecuritiesAlec Stranahan | $24 | 11.5% upside | |
| 2024-05-07 | H.C. WainwrightAndrew Maldonado | $40 | 85.8% upside | |
| 2023-01-08 | Piper SandlerJoseph Catanzaro | $45 | 109% upside | |
| 2022-12-15 | H.C. Wainwright | $35 | 62.6% upside | |
| 2022-12-14 | Needham | $40 | 85.8% upside | |
| 2022-12-05 | Goldman Sachs | $45 | 109% upside | |
| 2022-06-20 | Piper SandlerJoseph Catanzaro | $40 | 85.8% upside | |